Kratom, scientifically known as Mitragyna speciosa, is a tropical tree native to Southeast Asia. It has been traditionally used in countries like Thailand, Malaysia, and Indonesia for generations. According to a pharmacological review published in Frontiers in Psychiatry, kratom leaves were historically chewed fresh or brewed as tea by local laborers seeking energy and endurance during long workdays. Researchers note that its traditional use was embedded in social and cultural practices rather than recreational markets. Frontiers in Psychiatry – “The Chemical and Pharmacological Properties of Mitragyna speciosa” (2018)
Historical accounts describe kratom’s effects as dose-dependent. At lower amounts, users reported stimulant-like effects such as increased alertness. At higher amounts, reports described more calming properties. The National Institute on Drug Abuse (NIDA) explains that “people report that kratom can produce stimulant effects in low doses and sedative effects in higher doses,” reflecting its complex interaction with multiple receptor systems. National Institute on Drug Abuse – Kratom DrugFacts
Modern scientific interest focuses on kratom’s primary alkaloids, mitragynine and 7-hydroxymitragynine. A review in the journal Drug and Alcohol Dependence states that mitragynine acts as a partial agonist at mu-opioid receptors and also interacts with adrenergic and serotonergic pathways, helping explain its varied reported effects. Researchers emphasize that these compounds function differently from traditional opioids, though they still bind to some of the same receptors. Drug and Alcohol Dependence – “Kratom alkaloids: Interactions with opioid receptors” (2019
The U.S. Food and Drug Administration has raised safety concerns, noting that kratom “appears to have properties that expose users to the risks of addiction, abuse, and dependence.” Federal agencies continue to evaluate contamination risks, product variability, and labeling accuracy. Because kratom products are not federally standardized, potency and purity can vary significantly between manufacturers. U.S. Food and Drug Administration – FDA and Kratom
At the same time, researchers are studying kratom’s metabolism and potential therapeutic applications. A publication in the journal Molecules explains that ongoing research is examining kratom alkaloids for possible roles in pain management and substance use disorder research, but emphasizes that “clinical data remain limited and further controlled studies are required.” This cautious tone reflects the broader plant science approach seen in Cannabis, Hemp, CBD, and THC research—where early findings must be supported by controlled trials. Molecules – “Mitragynine and Its Derivatives: Physiological and Therapeutic Insights” (2021)
Today, kratom remains legal at the federal level in the United States but is restricted in some states and municipalities. Policy discussions often mirror debates seen in Cannabis Legalization and Marijuana Legalization, where public safety, traditional use, scientific evidence, and regulatory oversight intersect. Plant science education requires separating historical use from modern marketing claims and focusing on peer-reviewed research and verified data.
As part of High Science’s broader plant science mission, kratom serves as an example of how traditional botanical knowledge meets modern pharmacology. Understanding its history, chemistry, and regulatory landscape allows readers to engage in informed discussions rooted in science rather than speculation.
All information presented is for educational purposes only and focuses on plant science research and emerging studies. This content does not replace professional medical advice. Always consult licensed healthcare providers or trained professionals in plant-based science and natural health disciplines. All information provided is thought to be put to date with modern research and you should still do your own research and consult with professionals.
